Adare Pharmaceuticals Company Spotlight Presentation at BIO International 2016 Convention
San Francisco, CA – June 6, 2016
Adare Pharmaceuticals, a global specialty pharmaceutical company, will present its company overview on Tuesday, June 7, at 1:45 PM, in Room 1, at the 2016 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year’s convention will take place June 6-9 at the Moscone Center in San Francisco, California.
Building on a foundation of innovation, Adare has a strong growth trajectory through growth of its marketed product portfolio, internal pipeline, and our expertise in adding value to existing molecules guides our acquisition strategy of targeted assets. Adare has more than 40 products incorporating its proprietary technologies that are commercialized around the world.
Through established partnerships, Adare continues to advance healthcare. To explore partnership opportunities, schedule a meeting with Adare at BIO 2016 through the “BIO One-onOne PartneringTM System”, or contact Adare at “BusDev@adarepharma.com”. Learn more at “www.AdarePharma.com”
About the BIO International Convention
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
About Adare Pharmaceuticals
Adare Pharmaceuticals provides enhanced medicines, creating new possibilities for improved patient health. For decades, the company has solved complex formulation, manufacturing and commercialization challenges, resulting in transformational medicines that deliver value to all its stakeholders. Adare Pharmaceuticals has a global presence with R&D, manufacturing and commercial operations in the Unites States, Europe and Canada. For more information, visit “www.adarepharma.com”
Stacy McDonald-Mickey on behalf of Adare Pharmaceuticals, Inc.